Real Imaging's revolutionary technology - MIRA (Metabolic Imaging and Risk Assessment) - performs a 3D functional metabolic imaging of the breast. The data, a series of imaging biomarkers, is analyzed utilizing a wide range of sophisticated proprietary methods and algorithms. The result is an objective, computer generated, assessment of the health status of the breast, without the need for human interpretation
MIRA technology is intended to provide a non-invasive non-radiation, and examinee-friendly procedure to determine breast health through the acquisition and analysis of 3D imaging biomarkers. Following a short screening procedure, the 3D MIRA results are immediately available and presented as a non-subjective report to the examiner and the patient.
Real Imaging's MIRA system has the potential to deliver an effective and economical method that will enable clinical screening that is not limited by a woman's age, breast density or breast shape. Screening can be performed as often as needed without the risk of radiation.